USFDA completes inspection at Solara Active Pharma's Cuddalore manufacturing facility

08 Jul 2019 Evaluate

United States Food and Drug Administration (USFDA) has completed inspection at Solara Active Pharma Science’s multi-product manufacturing facility at Cuddalore with ZERO 483s inspectional observations.

The USFDA inspection at the facility was scheduled and completed between July 1, 2019 and July 5, 2019. The company continues to stay focused on maintaining the highest level of compliance across its manufacturing facilities. This is company’s third consecutive US FDA audit with Zero 483s.

Solara Active Pharma Sciences is a young, dynamic, entrepreneurial and customer oriented API manufacturer.

Solara Active Pharma Share Price

686.95 -33.60 (-4.66%)
20-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1808.50
Dr. Reddys Lab 1342.45
Cipla 1472.45
Lupin 2147.55
Zydus Lifesciences 973.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.